Chronic insulin exposure does not cause insulin resistance but is associated with chemo-resistance in colon cancer cells

Hormone and Metabolic Research

Volumn 46, Issue 2, 2014, Pages 85-93

  Baricevic, I ^a   Roberts, D L ^a   Renehan, A G ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

chemo resistance; colon cancer; insulin receptor; insulin receptor substrate; insulin resistance

Indexed keywords

CACO-2 CELLS; COLONIC NEOPLASMS; DRUG RESISTANCE, NEOPLASM; HCT116 CELLS; HT29 CELLS; HUMANS; INSULIN; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN RESISTANCE; MUTATION; NEOPLASTIC CELLS, CIRCULATING; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, IGF TYPE 1; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION;

EID: 84894289173     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0033-1354414     Document Type: Article

References (43)

1. Renehan A., Tyson M., Egger M., Heller R. F., Zwahlen M. Body mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet: 2008; 371 569 578 (Pubitemid 351232031)
2. Hursting S. D. Minireview: the year in obesity and cancer. Mol Endocrinol: 2012; 26 1961 1966
3. Inoue M., Tsugane S. Insulin resistance and cancer: epidemiological evidence. Endocr Relat Cancer: 2012; 19 F1 F8
4. Campbell P. T., Newton C. C., Dehal A. N., Jacobs E. J., Patel A. V., Gapstur S. M. Impact of body mass index on survival after colorectal cancer diagnosis: the Cancer Prevention Study-II Nutrition Cohort. J Clin Oncol: 2012; 30 42 52
5. Sinicrope F. A., Foster N. R., Yothers G., Benson A., Seitz J. F., Labianca R., Goldberg R. M., Degramont A., O'Connell M. J., Sargent D. J. Body mass index at diagnosis and survival among colon cancer patients enrolled in clinical trials of adjuvant chemotherapy. Cancer: 2013; 119 1528 1536
6. Wolpin B. M., Meyerhardt J. A., Chan A. T., Ng K., Chan J. A., Wu K., Pollak M. N., Giovannucci E. L., Fuchs C. S. Insulin, the insulin-like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer. J Clin Oncol: 2009; 27 176 185
7. Smith U., Gale E. A. Does diabetes therapy influence the risk of cancer? Diabetologia: 2009; 52 1699 1708
8. Varewijck A. J., Janssen J. A. Insulin and its analogues and their affinities for the IGF1 receptor. Endocr Relat Cancer: 2012; 19 F63 F75
9. Cohen D. H., LeRoith D. Obesity, type 2 diabetes, and cancer: the insulin and IGF connection. Endocr Relat Cancer: 2012; 19 F27 F45
10. Cohen P. The twentieth century struggle to decipher insulin signalling. Nat Rev Mol Cell Biol: 2006; 7 867 873 (Pubitemid 44627480)
11. Copps K. D., White M. F. Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2. Diabetologia: 2012; 55 2565 2582
12. Huang X. F., Chen J. Z. Obesity, the PI3K/Akt signal pathway and colon cancer. Obes Rev: 2009; 10 610 616
13. Hanahan D., Weinberg R. A. Hallmarks of cancer: the next generation. Cell: 2011; 144 646 674
14. Zoncu R., Efeyan A., Sabatini D. M. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol: 2011; 12 21 35
15. Myers M. G. Jr, Sun X. J., Cheatham B., Jachna B. R., Glasheen E. M., Backer J. M., White M. F. IRS-1 is a common element in insulin and insulin-like growth factor-I signaling to the phosphatidylinositol 3′-kinase. Endocrinology: 1993; 132 1421 1430 (Pubitemid 23110508)
16. Sun X. J., Miralpeix M., Myers M. G. Jr, Glasheen E. M., Backer J. M., Kahn C. R., White M. F. Expression and function of IRS-1 in insulin signal transmission. J Biol Chem: 1992; 267 22662 22672
17. Wang L. M., Myers M. G. Jr, Sun X. J., Aaronson S. A., White M., Pierce J. H. IRS-1: essential for insulin- and IL-4-stimulated mitogenesis in hematopoietic cells. Science: 1993; 261 1591 1594 (Pubitemid 23319604)
18. Bertacca A., Ciccarone A., Cecchetti P., Vianello B., Laurenza I., Del Prato S., Benzi L. High insulin levels impair intracellular receptor trafficking in human cultured myoblasts. Diabetes Res Clin Pract: 2007; 78 316 323 (Pubitemid 350047510)
19. Sasaoka T., Wada T., Ishihara H., Takata Y., Haruta T., Usui I., Ishiki M., Kobayashi M. Synergistic role of the phosphatidylinositol 3-kinase and mitogen-activated protein kinase cascade in the regulation of insulin receptor trafficking. Endocrinology: 1999; 140 3826 3834 (Pubitemid 30645440)
20. Cunningham D., Atkin W., Lenz H. J., Lynch H. T., Minsky B., Nordlinger B., Starling N. Colorectal cancer. Lancet: 2010; 375 1030 1047
21. Fischel J. L., Rostagno P., Formento P., Dubreuil A., Etienne M. C., Milano G. Ternary combination of irinotecan, fluorouracil-folinic acid and oxaliplatin: results on human colon cancer cell lines. Br J Cancer: 2001; 84 579 585 (Pubitemid 32215889)
22. Gual P., Le Marchand-Brustel Y., Tanti J. F. Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. Biochimie: 2005; 87 99 109 (Pubitemid 40298772)
23. Dallas N. A., Xia L., Fan F., Gray M. J., Gaur P., van Buren G. 2nd, Samuel S., Kim M. P., Lim S. J., Ellis L. M. Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition. Cancer Res: 2009; 69 1951 1957
24. Seth R., Crook S., Ibrahem S., Fadhil W., Jackson D., Ilyas M. Concomitant mutations and splice variants in KRAS and BRAF demonstrate complex perturbation of the Ras/Raf signalling pathway in advanced colorectal cancer. Gut: 2009; 58 1234 1241
25. Pierre-Eugene C., Pagesy P., Nguyen T. T., Neuille M., Tschank G., Tennagels N., Hampe C., Issad T. Effect of insulin analogues on insulin/IGF1 hybrid receptors: increased activation by glargine but not by its metabolites M1 and M2. PLoS One: 2012; 7 e41992
26. Renehan A. G., Dive C. Obesity, insulin and chemoresistance in colon cancer. J Gastrointest Oncol: 2011; 2 8 10
27. Vichai V., Kirtikara K. Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protoc: 2006; 1 1112 1116
28. Wood I. S., De Heredia F. P., Wang B., Trayhurn P. Cellular hypoxia and adipose tissue dysfunction in obesity. Proc Nutr Soc: 2009; 68 370 377
29. Kang S. G., Brown A. L., Chung J. H. Oxygen tension regulates the stability of insulin receptor substrate-1 (IRS-1) through caspase-mediated cleavage. J Biol Chem: 2007; 282 6090 6097 (Pubitemid 47100860)
30. Roberts D. L., Williams K. J., Cowen R. L., Barathova M., Eustace A. J., Brittain-Dissont S., Tilby M. J., Pearson D. G., Ottley C. J., Stratford I. J., Dive C. Contribution of HIF-1 and drug penetrance to oxaliplatin resistance in hypoxic colorectal cancer cells. Br J Cancer: 2009; 101 1290 1297
31. Roberts D. L., Dive C., Renehan A. G. Biological mechanisms linking obesity and cancer risk: new perspectives. Annu Rev Med: 2010; 61 301 316
32. Clayton P. E., Banerjee I., Murray P. G., Renehan A. G. Growth hormone, the insulin-like growth factor axis, insulin and cancer risk. Nature reviews Endocrinology: 2011; 7 11 24
33. Renehan A. G., Frystyk J., Flyvbjerg A. Obesity and cancer risk: the role of the insulin-IGF axis. Trends Endocrinol Metab: 2006; 17 328 336 (Pubitemid 44397568)
34. Calle E. E., Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer: 2004; 4 579 591 (Pubitemid 39025053)
35. Park E. J., Lee J. H., Yu G. Y., He G., Ali S. R., Holzer R. G., Osterreicher C. H., Takahashi H., Karin M. Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell: 2010; 140 197 208
36. Pollak M. Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer: 2008; 8 915 928
37. Belfiore A., Malaguarnera R. Insulin receptor and cancer. Endocr Relat Cancer: 2011; 18 R125 R147
38. Ulanet D. B., Ludwig D. L., Kahn C. R., Hanahan D. Insulin receptor functionally enhances multistage tumor progression and conveys intrinsic resistance to IGF-1R targeted therapy. Proc Natl Acad Sci USA: 2010; 107 10791 10798
39. Dearth R. K., Cui X., Kim H. J., Kuiatse I., Lawrence N. A., Zhang X., Divisova J., Britton O. L., Mohsin S., Allred D. C., Hadsell D. L., Lee A. V. Mammary tumorigenesis and metastasis caused by overexpression of insulin receptor substrate 1 (IRS-1) or IRS-2. Mol Cell Biol: 2006; 26 9302 9314 (Pubitemid 44904425)
40. Bilanges B., Vanhaesebroeck B. A new tool to dissect the function of p70 S6 kinase. Biochem J: 2010; 431 e1 e3
41. Um S. H., Frigerio F., Watanabe M., Picard F., Joaquin M., Sticker M., Fumagalli S., Allegrini P. R., Kozma S. C., Auwerx J., Thomas G. Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature: 2004; 431 200 205 (Pubitemid 39243474)
42. Tremblay F., Brule S., Hee Um S., Li Y., Masuda K., Roden M., Sun X. J., Krebs M., Polakiewicz R. D., Thomas G., Marette A. Identification of IRS-1 Ser-1101 as a target of S6K1 in nutrient- and obesity-induced insulin resistance. Proc Natl Acad Sci USA: 2007; 104 14056 14061 (Pubitemid 350003334)
43. Hansen B. F. Insulin analogues with increased mitogenic potency - are they safe? Horm Metab Res: 2008; 40 431 433 (Pubitemid 351967137)